Traws Pharma, Inc.
TRAW
$0.83
-$0.01-0.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.13M | 3.82M | 6.42M | 13.08M | 15.94M |
| Total Receivables | 1.69M | 3.79M | 1.99M | 1.32M | 1.65M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 135.00K | 234.00K | 332.00K | 49.00K | 149.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 710.00K | 131.00K | 882.00K | 917.00K | 1.12M |
| Total Current Assets | 5.67M | 7.98M | 9.63M | 15.37M | 18.86M |
|
|
|||||
| Total Current Assets | 5.67M | 7.98M | 9.63M | 15.37M | 18.86M |
| Net Property, Plant & Equipment | 6.00K | 7.00K | 7.00K | 8.00K | 9.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.48M | 2.53M | 2.57M | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.00K | 104.00K | 240.00K | 244.00K | 198.00K |
| Total Assets | 8.16M | 10.62M | 12.44M | 15.62M | 19.06M |
|
|
|||||
| Total Accounts Payable | 7.67M | 5.65M | 5.11M | 4.76M | 7.66M |
| Total Accrued Expenses | 5.54M | 5.37M | 2.78M | 2.59M | 2.52M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 128.00K | -- | -- | 226.00K |
| Total Other Current Liabilities | -- | 128.00K | -- | -- | 226.00K |
| Total Current Liabilities | 13.21M | 11.15M | 7.89M | 7.35M | 10.40M |
|
|
|||||
| Total Current Liabilities | 13.21M | 11.15M | 7.89M | 7.35M | 10.40M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 259.00K | 100.00K | 11.00K | 8.00K | 2.66M |
| Total Liabilities | 13.47M | 11.25M | 7.90M | 7.36M | 13.06M |
|
|
|||||
| Common Stock & APIC | 641.78M | 639.35M | 637.08M | 636.83M | 633.68M |
| Retained Earnings | -647.09M | -639.98M | -632.54M | -628.58M | -627.66M |
| Treasury Stock & Other | -2.00K | 6.00K | 6.00K | 9.00K | -19.00K |
| Total Common Equity | -5.31M | -629.00K | 4.55M | 8.26M | 6.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.31M | -629.00K | 4.55M | 8.26M | 6.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.31M | -629.00K | 4.55M | 8.26M | 6.00M |
|
|
|||||